Jurgen Wess

Company: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Job title: Section Chief of Molecular Signaling Section

Seminars:

Chemogenetic Activation of Specific GPCR Signaling Pathways to Identify Novel Targets for Antidiabetic Drugs 12:00 pm

Leveraging designer GPCRs known as DREADDs (Designer Receptors Exclusively Activated by a Designer Drug) to selectively activate distinct classes of heterotrimeric G proteins Using DREADDs to identify novel cellular targets for the treatment of major metabolic disorders Optimizing DREADD technology to identify distinct GPCR signaling pathways involved in type 2 diabetes and obesity in vivoRead more

day: Day One Track A AM